ConductScience.org, home

Paper32086972

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.

Dubey D and 9 others. Ann Neurol, 2020. Cited by 173 papers, by iCite.

Cite this record

ConductScience Library. Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum. Papers, record 32086972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32086972

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.
PubMed
Journal
Ann Neurol
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
173
iCite
Relative citation ratio, by iCite
8.47
iCite
Revised in PubMed
2020-07-23
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dubey DDivyanshuhttps://orcid.org/0000-0002-4302-4075
2David WSWilliam S
3Reynolds KLKerry L
4Chute DFDonald F
5Clement NFNathan F
6Cohen JVJustine V
7Lawrence DPDonald P
8Mooradian MJMeghan J
9Sullivan RJRyan J
10Guidon ACAmanda C

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, ImmunologicalMajor topic
Neurotoxicity SyndromesMajor topic
Humans

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in32368808Reply to "Value of Onconeural Antibodies in Checkpoint Inhibitor-Related Toxicities".https://conductscience.org/library/papers/32368808PubMed
Comment in32386101Value of Onconeural Antibodies in Checkpoint Inhibitor-Related Toxicities.https://conductscience.org/library/papers/32386101PubMed

Download CSV of comments and corrections

Cited by113

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 173 citations.

PMIDTitleJournalYearIn PapersSource
42856915Efficacy and safety of immunotherapy in pediatric malignant brain tumors: a systematic review and exploratory meta-analysis.Front Oncol2026https://conductscience.org/library/papers/42856915PubMed
42853526Paraneoplastic Intracellular Neuropathies: A Narrative Review.Neurol Ther2026https://conductscience.org/library/papers/42853526PubMed
42841091Triple M Overlap Syndrome: A Rare Complication of Immune Checkpoint Inhibitors.Cureus2026https://conductscience.org/library/papers/42841091PubMed
42683203Immune-Related Encephalitis in a Patient With Pleural Mesothelioma: Case Report.Respirol Case Rep2026https://conductscience.org/library/papers/42683203PubMed
42488653
Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization.
Front Immunol2026https://conductscience.org/library/papers/42488653PubMed
42488081Immune Checkpoint Inhibitor Associated Myopathy with Concurrent Myocardial Injury: A Retrospective Cohort Study.Int J Gen Med2026https://conductscience.org/library/papers/42488081PubMed
42342405Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae.J Immunother Cancer2026https://conductscience.org/library/papers/42342405PubMed
42227599Severe Immune-Related Neurological Adverse Events Associated With Immune Checkpoint Inhibitor Treatment: A Retrospective Single-Center Study.Eur J Neurol2026https://conductscience.org/library/papers/42227599PubMed
42222387Case Report: Neurological immune-related adverse events with anti-PD-1 based immunotherapy in cervical cancer.Front Oncol2026https://conductscience.org/library/papers/42222387PubMed
42148066Severe neuromyelitis optica spectrum disorder induced by pucotenlimab: a case report and literature review.Front Immunol2026https://conductscience.org/library/papers/42148066PubMed
42029801Characterizing the effects of anti-PD1 immunotherapy on ataxia in a vestibular schwannoma mouse model.J Neurooncol2026https://conductscience.org/library/papers/42029801PubMed
41710645Successful Plasma Exchange and Steroid Maintenance Therapy for Severe Pembrolizumab-Induced Polyradiculoneuritis in Lung Cancer: A Case Report.Case Rep Oncol2026https://conductscience.org/library/papers/41710645PubMed
41488641Evaluation of warning strategies for paraneoplastic neurological syndromes associated with PD-1/PD-L1 inhibitors.Front Immunol2025https://conductscience.org/library/papers/41488641PubMed
41477245Encephalitis and Immune-Related Complications in a Patient Treated With Nivolumab: A Case Report.Case Rep Med2025https://conductscience.org/library/papers/41477245PubMed
41463186Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare System.Cancers (Basel)2025https://conductscience.org/library/papers/41463186PubMed
41367883Fatal Steroid-Refractory Autoimmune Encephalitis Following Sequential Immune Checkpoint Inhibitor Therapy in Squamous Non-Small Cell Lung Cancer.Onco Targets Ther2025https://conductscience.org/library/papers/41367883PubMed
41350408Incidence and outcomes of neuromuscular immune-related adverse events in head and neck cancer patients treated with checkpoint inhibitors.Sci Rep2025https://conductscience.org/library/papers/41350408PubMed
41290313Neurological immune-related adverse events after ICI treatment: a protocol for an overview of systematic reviews.BMJ Open2025https://conductscience.org/library/papers/41290313PubMed
41052400Outcomes in Patients With Immune Checkpoint Inhibitor-Related Myopathy and Prolonged Follow-Up.Neurol Neuroimmunol Neuroinflamm2025https://conductscience.org/library/papers/41052400PubMed
40987493HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis.J Immunother Cancer2025https://conductscience.org/library/papers/40987493PubMed

See all 113 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32086972

GET https://conductscience.org/api/papers/v1/32086972/cited_by?page=2